1. Home
  2. LAW vs MDWD Comparison

LAW vs MDWD Comparison

Compare LAW & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAW
  • MDWD
  • Stock Information
  • Founded
  • LAW 2013
  • MDWD 2000
  • Country
  • LAW United States
  • MDWD Israel
  • Employees
  • LAW N/A
  • MDWD N/A
  • Industry
  • LAW Computer Software: Prepackaged Software
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • LAW Technology
  • MDWD Health Care
  • Exchange
  • LAW Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • LAW 259.6M
  • MDWD 208.2M
  • IPO Year
  • LAW 2021
  • MDWD 2014
  • Fundamental
  • Price
  • LAW $4.10
  • MDWD $20.86
  • Analyst Decision
  • LAW Buy
  • MDWD Strong Buy
  • Analyst Count
  • LAW 2
  • MDWD 2
  • Target Price
  • LAW $6.75
  • MDWD $35.00
  • AVG Volume (30 Days)
  • LAW 138.3K
  • MDWD 59.4K
  • Earning Date
  • LAW 08-06-2025
  • MDWD 08-13-2025
  • Dividend Yield
  • LAW N/A
  • MDWD N/A
  • EPS Growth
  • LAW N/A
  • MDWD N/A
  • EPS
  • LAW N/A
  • MDWD N/A
  • Revenue
  • LAW $145,923,000.00
  • MDWD $19,213,000.00
  • Revenue This Year
  • LAW $6.11
  • MDWD $20.64
  • Revenue Next Year
  • LAW $6.46
  • MDWD $25.71
  • P/E Ratio
  • LAW N/A
  • MDWD N/A
  • Revenue Growth
  • LAW 3.84
  • MDWD N/A
  • 52 Week Low
  • LAW $3.31
  • MDWD $14.14
  • 52 Week High
  • LAW $6.64
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • LAW 45.31
  • MDWD 58.02
  • Support Level
  • LAW $4.05
  • MDWD $20.00
  • Resistance Level
  • LAW $4.21
  • MDWD $21.11
  • Average True Range (ATR)
  • LAW 0.14
  • MDWD 0.78
  • MACD
  • LAW -0.03
  • MDWD 0.11
  • Stochastic Oscillator
  • LAW 21.31
  • MDWD 81.92

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: